138 related articles for article (PubMed ID: 20039175)
41. National patterns of care and predictors of neoadjuvant and concurrent chemotherapy use with definitive radiotherapy in the treatment of patients with oropharyngeal squamous cell carcinoma.
Sher DJ; Rusthoven CG; Khan SA; Fidler MJ; Zhu H; Koshy M
Cancer; 2017 Jan; 123(2):273-282. PubMed ID: 27649421
[TBL] [Abstract][Full Text] [Related]
42. Swallowing function after chemoradiation for advanced stage oropharyngeal cancer.
Shiley SG; Hargunani CA; Skoner JM; Holland JM; Wax MK
Otolaryngol Head Neck Surg; 2006 Mar; 134(3):455-9. PubMed ID: 16500444
[TBL] [Abstract][Full Text] [Related]
43. Quality of life in patients with oropharynx carcinomas: assessment after accelerated radiotherapy with or without chemotherapy versus radical surgery and postoperative radiotherapy.
Allal AS; Nicoucar K; Mach N; Dulguerov P
Head Neck; 2003 Oct; 25(10):833-9; discussion 839-40. PubMed ID: 12966507
[TBL] [Abstract][Full Text] [Related]
44. Effect of body mass index on chemoradiation outcomes in head and neck cancer.
McRackan TR; Watkins JM; Herrin AE; Garrett-Mayer EM; Sharma AK; Day TA; Gillespie MB
Laryngoscope; 2008 Jul; 118(7):1180-5. PubMed ID: 18475213
[TBL] [Abstract][Full Text] [Related]
45. Effects of exercise on swallowing and tongue strength in patients with oral and oropharyngeal cancer treated with primary radiotherapy with or without chemotherapy.
Lazarus CL; Husaini H; Falciglia D; DeLacure M; Branski RC; Kraus D; Lee N; Ho M; Ganz C; Smith B; Sanfilippo N
Int J Oral Maxillofac Surg; 2014 May; 43(5):523-30. PubMed ID: 24332586
[TBL] [Abstract][Full Text] [Related]
46. Changing failure patterns in oropharyngeal squamous cell carcinoma treated with intensity modulated radiotherapy and implications for future research.
Yao M; Nguyen T; Buatti JM; Dornfeld KJ; Tan H; Wacha J; Bayouth JE; Clamon GH; Funk GF; Smith RB; Chang K; Hoffman HT
Am J Clin Oncol; 2006 Dec; 29(6):606-12. PubMed ID: 17148999
[TBL] [Abstract][Full Text] [Related]
47. Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer - A case matched analysis.
Blanchard P; Garden AS; Gunn GB; Rosenthal DI; Morrison WH; Hernandez M; Crutison J; Lee JJ; Ye R; Fuller CD; Mohamed AS; Hutcheson KA; Holliday EB; Thaker NG; Sturgis EM; Kies MS; Zhu XR; Mohan R; Frank SJ
Radiother Oncol; 2016 Jul; 120(1):48-55. PubMed ID: 27342249
[TBL] [Abstract][Full Text] [Related]
48. Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: clinical outcomes and patterns of failure.
Daly ME; Le QT; Maxim PG; Loo BW; Kaplan MJ; Fischbein NJ; Pinto H; Chang DT
Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1339-46. PubMed ID: 19540068
[TBL] [Abstract][Full Text] [Related]
49. Validation of the 8
van Gysen K; Stevens M; Guo L; Jayamanne D; Veivers D; Wignall A; Pang L; Guminski A; Lee A; Hruby G; Macleod P; Taylor A; Eade T
BMC Cancer; 2019 Jul; 19(1):674. PubMed ID: 31288767
[TBL] [Abstract][Full Text] [Related]
50. Predictors of speech and swallowing function following primary surgery for oral and oropharyngeal cancer.
Zuydam AC; Lowe D; Brown JS; Vaughan ED; Rogers SN
Clin Otolaryngol; 2005 Oct; 30(5):428-37. PubMed ID: 16232247
[TBL] [Abstract][Full Text] [Related]
51. Treatment modality impact on quality of life for human papillomavirus-associated oropharynx cancer.
Xu MJ; Plonowska KA; Gurman ZR; Humphrey AK; Ha PK; Wang SJ; El-Sayed IH; Heaton CM; George JR; Yom SS; Algazi AP; Ryan WR
Laryngoscope; 2020 Feb; 130(2):E48-E56. PubMed ID: 30919470
[TBL] [Abstract][Full Text] [Related]
52. Modern treatment outcomes for early T-stage oropharyngeal cancer treated with intensity-modulated radiation therapy at a tertiary care institution.
Di Gravio EJ; Lang P; Kim HAJ; Chinnery T; Mundi N; MacNeil SD; Mendez A; Yoo J; Fung K; Mymryk JS; Barrett JW; Read N; Venkatesan V; Kuruvilla S; Mendez LC; Winquist E; Mitchell S; Mattonen SA; Nichols AC; Palma DA
Radiat Oncol; 2020 Nov; 15(1):261. PubMed ID: 33168055
[TBL] [Abstract][Full Text] [Related]
53. Concurrent chemoradiotherapy with helical tomotherapy for oropharyngeal cancer: a preliminary result.
Shueng PW; Wu LJ; Chen SY; Hsiao CH; Tien HJ; Cheng PW; Kuo YS; Chen YJ; Chen CA; Hsieh PY; Hsieh CH
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):715-21. PubMed ID: 19879069
[TBL] [Abstract][Full Text] [Related]
54. Two-step Intensity-modulated Radiation Therapy for Oropharyngeal Cancer: Initial Clinical Experience and Validation of Clinical Staging.
Tatebe H; Doi H; Ishikawa K; Kawakami H; Yokokawa M; Nakamatsu K; Kanamori S; Shibata T; Kitano M; Nishimura Y
Anticancer Res; 2018 Feb; 38(2):979-986. PubMed ID: 29374730
[TBL] [Abstract][Full Text] [Related]
55. Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy.
Furness S; Glenny AM; Worthington HV; Pavitt S; Oliver R; Clarkson JE; Macluskey M; Chan KK; Conway DI;
Cochrane Database Syst Rev; 2010 Sep; (9):CD006386. PubMed ID: 20824847
[TBL] [Abstract][Full Text] [Related]
56. What patients consider important: temporal variations by early and late stage oral, oropharyngeal and laryngeal subsites.
Metcalfe CW; Lowe D; Rogers SN
J Craniomaxillofac Surg; 2014 Jul; 42(5):641-7. PubMed ID: 24238983
[TBL] [Abstract][Full Text] [Related]
57. Analysis of prognostic factors in patients with oropharyngeal squamous cell carcinoma treated with radiotherapy alone or in combination with systemic chemotherapy.
Pedruzzi PA; Kowalski LP; Nishimoto IN; Oliveira BV; Tironi F; Ramos GH
Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1196-204. PubMed ID: 19015451
[TBL] [Abstract][Full Text] [Related]
58. Clinical results of definitive intensity-modulated radiation therapy for oropharyngeal cancer: retrospective analysis of treatment efficacy and safety.
Kimura K; Kodaira T; Tomita N; Tachibana H; Makita C; Yoshida M; Nishikawa D; Hirakawa H; Suzuki H; Hanai N; Hasegawa Y
Jpn J Clin Oncol; 2016 Jan; 46(1):78-85. PubMed ID: 26496935
[TBL] [Abstract][Full Text] [Related]
59. Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study.
Chen AM; Felix C; Wang PC; Hsu S; Basehart V; Garst J; Beron P; Wong D; Rosove MH; Rao S; Melanson H; Kim E; Palmer D; Qi L; Kelly K; Steinberg ML; Kupelian PA; Daly ME
Lancet Oncol; 2017 Jun; 18(6):803-811. PubMed ID: 28434660
[TBL] [Abstract][Full Text] [Related]
60. Comparisons of dysphagia and quality of life (QOL) in comparable patients with HPV-positive oropharyngeal cancer receiving chemo-irradiation or cetuximab-irradiation.
Samuels SE; Tao Y; Lyden T; Haxer M; Spector M; Malloy KM; Prince ME; Bradford CR; Worden FP; Schipper M; Eisbruch A
Oral Oncol; 2016 Mar; 54():68-74. PubMed ID: 26776757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
